South Korea Neuropathic Pain Market Size & Outlook, 2025-2033


South Korea Neuropathic Pain Market Insights

  • As highlighted in Reed Intelligence analysis, the South Korea Neuropathic Pain Market, worth USD 167.83 Million in 2024, is forecasted to achieve USD 255.96 Million by 2033.
  • The South Korea market is anticipated to grow at a CAGR of 4.87% during the period 2026–2033.
  • By 2024, Peripheral Neuropathy represented the largest share of the By Type market size.
  • Focal Neuropathy is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • South Korea contributed 1.9% to the global Neuropathic Pain Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Neuropathic Pain Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2033.
  • Among Asia Pacific markets, Singapore is expected to post the fastest growth, reaching USD 98.41 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 167.83 Million
Market Size In 2033 USD 255.96 Million
Largest segment Peripheral Neuropathy
Units Revenue in USD Million
CAGR 4.87% (2025-2033)
Segmnetation Covered
By Type
  1. Peripheral Neuropathy
  2. Proximal Neuropathy
  3. Focal Neuropathy
  4. Autonomic Neuropathy
By Treatment
  1. Drug-Based
  2. Non-Drug Based
  3. By Route of Administration
  4. By Distribution Channel
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports